Johnson & Johnson Innovation Jjdc Inc investment portfolio

AviadoBio creates gene‑therapy medicines and delivery technologies that target neurodegenerative disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer’s disease, tauopathies and retinal conditions. Its platform combines next‑generation gene‑therapy design with neuroscience expertise and a neuroanatomy‑led approach to deliver treatments to the brain and eye.

Cellular Origins develops and supplies automated manufacturing solutions for cell and gene therapies, using its mobile‑robotic, AI‑driven platform (Constellation) to coordinate the movement of patient material and equipment at commercial scale. Its customers are biopharma companies that produce cell‑based therapeutic products.